Haoxi Health Technology Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Haoxi Health Technology Limited, a foreign private issuer, on November 6, 2024. The filing covers the month of November 2024 and serves to disclose a material event regarding the company's listing status on the Nasdaq stock exchange.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a regulatory event rather than a financial results announcement.
Material Changes
The primary material change disclosed is the receipt of a notification from Nasdaq indicating a deficiency in the company's minimum bid price. This suggests the company's stock price has fallen below the required threshold for continued listing.
Guidance, Outlook, and Risks
Management commentary is limited to the disclosure of the Nasdaq notification. The filing highlights a significant risk to the company's continued listing status on the Nasdaq Capital Market. No specific guidance, outlook, or details on remediation plans are included in this specific document.
Investor Verification Checklist
- Verify the current stock price relative to the Nasdaq minimum bid price requirement (typically $1.00).
- Review the full text of the Nasdaq notification (Exhibit 99.1) for specific compliance deadlines.
- Check for subsequent filings regarding the company's plan to regain compliance or potential delisting risks.
- Confirm if the company has issued a separate press release detailing the deficiency and proposed actions.